APA (7th ed.) Citation

H, R., E, A., T, B., J, H., L, K., J, S., . . . L, L. (2022). The use of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis postliver transplant: A case series. Pediatric pulmonology, 57(2), 411. https://doi.org/10.1002/ppul.25779

Chicago Style (17th ed.) Citation

H, Ragan, Autry E, Bomersback T, Hewlett J, Kormelink L, Safirstein J, Shanley L, and Lubsch L. "The Use of Elexacaftor/tezacaftor/ivacaftor in Patients with Cystic Fibrosis Postliver Transplant: A Case Series." Pediatric Pulmonology 57, no. 2 (2022): 411. https://doi.org/10.1002/ppul.25779.

MLA (9th ed.) Citation

H, Ragan, et al. "The Use of Elexacaftor/tezacaftor/ivacaftor in Patients with Cystic Fibrosis Postliver Transplant: A Case Series." Pediatric Pulmonology, vol. 57, no. 2, 2022, p. 411, https://doi.org/10.1002/ppul.25779.